alpha B crystallin translocation and phosphorylation: signal transduction pathways and preconditioning in the isolated rat heart

Philip Eaton, William Fuller, James R Bell, Michael J Shattock

    Research output: Contribution to journalArticlepeer-review

    52 Citations (Scopus)

    Abstract

    In this program of studies we have characterized in detail the translocation (assessed by Triton-insolubility) and phosphorylation (using serine-45 or -59 phosphospecific antibodies) of alphaB crystallin during myocardial ischemia [both with or without ischemic preconditioning (IPC)]. Pharmacological activators and inhibitors allowed us to characterize the signaling pathways involved in alphaB crystallin phosphorylation during ischemia. Ischemic preconditioning alone caused 30% of the heart's alphaB crystallin pool to translocate, providing a significant translocation 'head-start' in protected tissue. This enhanced translocation is coupled with increased (3-fold) alphaB crystallin phosphorylation at both serine residues. The possible role of aB crystallin in the protection afforded by ischemic preconditioning is supported by the signal transduction data: which showed preconditioning-induced aB crystallin phosphorylation,can be blocked by tyrosine kinase inhibition (using genistein) and by p38 MAP kinase or PKC inhibition (using SB203580 or bisindolylmaleimide, respectively). The activation of both p38 MAP kinase and PKC are recognized requirements for the induction of preconditioning and their inhibition is known to block protection. Western immunoblotting analysis after isoelectric focusing electrophoresis, confirmed the observations made with the phosphospecific antibodies: but also showed that 27 +/- 4% of total cardiac crystallin was phosphorylated after 30 min of ischemia. alphaB crystallin exists as large polymeric aggregates in cardiac tissue under basal conditions (approximate to 1MDa as determined by gel filtration chromatography). We induced phosphorylation of alphaB crystallin during aerobic perfusion by the administration of phenylephrine. However this treatment did not alter the molecular aggregate size of alphaB crystallin. It appears that alphaB crystallin molecular aggregate size is not simply regulated by phosphorylation. alphaB crystallin may have a role to play in the myocardial protection induced by ischemic preconditioning, as both translocation and phosphorylation are both accelerated and enhanced by ischemic preconditioning. (C) 2001 Academic Press.

    Original languageEnglish
    Pages (from-to)1659-1671
    Number of pages13
    JournalJournal of Molecular and Cellular Cardiology
    Volume33
    Issue number9
    DOIs
    Publication statusPublished - Sep 2001

    Cite this